Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medullary thyroid cancer.

E Kebebew1, O H Clark

  • 1Department of Surgery, University of California, San Francisco, UCSF/Mt. Zion Medical Center, Box 0470, S343, San Francisco, CA 94143, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.

Oncogene·2017
Same author

Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.

The Journal of clinical endocrinology and metabolism·2015
Same author

Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.

The Journal of clinical endocrinology and metabolism·2014
Same author

Functional thermogenic beige adipogenesis is inducible in human neck fat.

International journal of obesity (2005)·2013
Same author

KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.

Endocrine-related cancer·2012
Same author

The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.

Endocrine-related cancer·2012
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

This study outlines surgical and therapeutic strategies for medullary thyroid cancer (MTC). Recommendations cover primary tumor management, lymph node dissection, and treatment for persistent, recurrent, or metastatic MTC, including genetic screening implications.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Endocrinology

Background:

  • Medullary thyroid cancer (MTC) requires tailored management based on tumor stage and patient genetics.
  • Early detection and intervention are crucial for improving outcomes in MTC patients.

Purpose of the Study:

  • To provide evidence-based guidelines for the surgical and therapeutic management of medullary thyroid cancer.
  • To delineate treatment strategies for various stages of MTC, from early-stage disease to metastatic spread.

Main Methods:

  • Review of clinical evidence and expert consensus on MTC management.
  • Development of treatment algorithms based on tumor size, nodal status, genetic mutations, and disease recurrence.

Main Results:

Related Experiment Videos

  • Specific surgical recommendations include total thyroidectomy with comprehensive neck dissections based on tumor characteristics.
  • Management of advanced disease involves external radiotherapy, somatostatin analogs, surgical resection of metastases, and consideration of chemotherapy or targeted immunotherapy.
  • Prophylactic thyroidectomy is recommended for genetic carriers before age six.

Conclusions:

  • A multi-modal approach integrating surgery, radiotherapy, and systemic therapies is essential for optimal MTC patient care.
  • Genetic screening and early intervention significantly impact the management and prognosis of hereditary MTC.